Login / Signup

Neuronal intranuclear inclusion disease is genetically heterogeneous.

Zhongbo ChenWai Yan YauZane JaunmuktaneArianna TucciPrasanth SivakumarSarah A Gagliano TaliunChris TurnerStephanie EfthymiouKristina IbáñezRoisin SullivanFarah BibiAlkyoni Athanasiou-FragkouliThomas BourinarisDavid ZhangTamas ReveszTammaryn LashleyMichael DeTureGourisankar GhoshKeith Anthony JosephsEllen GelpiGábor G KovácsGlenda HallidayDominic B RoweIan BlairPentti J TienariAnu SuomalainenNick C FoxNicholas W WoodAndrew J LeesMatti J Haltianull nullJohn HardyMina RytenJana VandrovcovaHenry Houlden
Published in: Annals of clinical and translational neurology (2020)
Neuronal intranuclear inclusion disease (NIID) is a clinically heterogeneous neurodegenerative condition characterized by pathological intranuclear eosinophilic inclusions. A CGG repeat expansion in NOTCH2NLC was recently identified to be associated with NIID in patients of Japanese descent. We screened pathologically confirmed European NIID, cases of neurodegenerative disease with intranuclear inclusions and applied in silico-based screening using whole-genome sequencing data from 20 536 participants in the 100 000 Genomes Project. We identified a single European case harbouring the pathogenic repeat expansion with a distinct haplotype structure. Thus, we propose new diagnostic criteria as European NIID represents a distinct disease entity from East Asian cases.
Keyphrases